SEC filings
Solventum (SOLV)
Recent filings Solventum made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001964738All filings on SEC.gov
10-QQuarterly report
Quarterly report
Solventum announced its intention to separate its Health Information Systems business and reported second-quarter 2026 net sales of $2.209 billion, up 2.2% year over year with 9.5% organic growth. …
8-KCurrent report
Results of Operations and Financial Condition
Solventum reported second-quarter 2026 sales of $2.2 billion, up 2.2% on a reported basis and 9.5% organically, and said it intends to separate its Health Information Systems business segment while raising full-year 2026 guidance for…
8-KCurrent report
Regulation FD Disclosure; Other Events
Solventum announced its intention to pursue a separation of its Health Information Systems business, a healthcare software unit with $1.4 billion in annual sales, as part of its portfolio optimization strategy; …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Solventum Corporation appointed Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer, effective August 10, 2026, succeeding Mary Wilcox, who is retiring, and he will report to CFO Wayde McMillan. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Solventum in Readster
Add Solventum to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.